Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.

Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JR, Ahmed A.

PLoS One. 2010 May 4;5(5):e10456. doi: 10.1371/journal.pone.0010456.

2.

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.

Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A.

Oncogene. 2010 Apr 8;29(14):2036-46. doi: 10.1038/onc.2009.496. Epub 2010 Jan 18.

PMID:
20101234
3.

WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.

Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q.

Cancer Biol Ther. 2010 Sep 15;10(6):617-24. Epub 2010 Sep 7.

PMID:
20603606
4.

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.

Stigliano I, Puricelli L, Filmus J, Sogayar MC, Bal de Kier Joffé E, Peters MG.

Breast Cancer Res Treat. 2009 Mar;114(2):251-62. doi: 10.1007/s10549-008-0009-2. Epub 2008 Apr 11.

PMID:
18404367
5.

Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.

Thiele S, Rauner M, Goettsch C, Rachner TD, Benad P, Fuessel S, Erdmann K, Hamann C, Baretton GB, Wirth MP, Jakob F, Hofbauer LC.

J Cell Biochem. 2011 Jun;112(6):1593-600. doi: 10.1002/jcb.23070.

PMID:
21344486
6.
7.

Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.

Jin F, Qu X, Fan Q, Wang L, Tang T, Hao Y, Dai K.

Mol Med Rep. 2013 Nov;8(5):1486-92. doi: 10.3892/mmr.2013.1698. Epub 2013 Sep 23.

PMID:
24064566
8.

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.

PMID:
16465433
9.

Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.

Kim J, Kim J, Kim DW, Ha Y, Ihm MH, Kim H, Song K, Lee I.

J Immunol. 2010 Jul 15;185(2):1274-82. doi: 10.4049/jimmunol.1000181. Epub 2010 Jun 16.

10.

The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.

Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC.

Cancer Prev Res (Phila). 2009 Sep;2(9):830-41. doi: 10.1158/1940-6207.CAPR-09-0066. Epub 2009 Sep 8.

11.

WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.

Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q.

Clin Cancer Res. 2008 Jan 1;14(1):55-61. doi: 10.1158/1078-0432.CCR-07-1644.

12.

Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.

Chesire DR, Dunn TA, Ewing CM, Luo J, Isaacs WB.

Cancer Res. 2004 Apr 1;64(7):2523-33.

13.

Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.

Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.

Tumour Biol. 2013 Jun;34(3):1625-33. doi: 10.1007/s13277-013-0694-2. Epub 2013 Feb 16.

PMID:
23417837
15.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.

16.

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.

Wang Q, Williamson M, Bott S, Brookman-Amissah N, Freeman A, Nariculam J, Hubank MJ, Ahmed A, Masters JR.

Oncogene. 2007 Oct 4;26(45):6560-5. Epub 2007 May 7.

PMID:
17486081
17.

The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.

Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K.

Mol Cell Biol. 2003 Jan;23(1):131-9.

18.

Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.

Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.

Carcinogenesis. 2013 Nov;34(11):2629-38. doi: 10.1093/carcin/bgt215. Epub 2013 Jun 12.

19.

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.

Kawano Y, Diez S, Uysal-Onganer P, Darrington RS, Waxman J, Kypta RM.

Br J Cancer. 2009 Apr 7;100(7):1165-74. doi: 10.1038/sj.bjc.6604976. Epub 2009 Mar 10.

20.

Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.

Cheng R, Sun B, Liu Z, Zhao X, Qi L, Li Y, Gu Q.

J Cell Physiol. 2014 Dec;229(12):1908-17. doi: 10.1002/jcp.24566.

PMID:
24464650
Items per page

Supplemental Content

Write to the Help Desk